Table 2 Mean serum uric acid levels in the 3-month period after liver transplantation, according to patient characteristics
Mean serum uric acid (mg/dl) | |||
|---|---|---|---|
Characteristic | n | Mean (±SD) | P |
All | 304 | 6.9 (±2.3) | |
[median, 6.6] | |||
Age (years) | 0.08 | ||
≤ 50 | 119 | 6.6 (±2.3) | |
> 50 | 185 | 7.1 (±2.3) | |
Gender | 0.28 | ||
Male | 199 | 7.0 (±2.3) | |
Female | 105 | 6.7 (±2.3) | |
Race | 0.07 | ||
White | 216 | 7.1 (±2.3) | |
Black/Other | 88 | 6.6 (±2.3) | |
MELD era | 0.27 | ||
Before 2/2002 | 151 | 6.8 (±2.2) | |
After 2/2002 | 153 | 7.1 (±2.3) | |
eGFR Categorya at Tx | <0.0001 | ||
≥ 90 | 138 | 6.0 (±2.0) | |
60–89 | 66 | 7.3 (±2.0) | |
30–59 | 65 | 8.0 (±2.4) | |
< 30 | 31 | 7.9 (±2.1) | |
MELD score category | 0.052 | ||
< 20 | 177 | 6.7 (±2.2) | |
20–29 | 85 | 7.4 (±2.3) | |
≥ 30 | 38 | 7.1 (±2.1) | |
Diabetes | 0.18 | ||
No | 208 | 6.8 (±2.2) | |
Yes | 79 | 7.2 (±2.4) | |
Hypertension | 0.06 | ||
No | 228 | 6.8 (±2.3) | |
Yes | 55 | 7.4 (±2.4) | |
Hepatitis C Virus | 0.06 | ||
No | 150 | 6.7 (±2.4) | |
Yes | 139 | 7.2 (±2.1) | |
Mycophenolate mofetil | 0.63 | ||
No | 124 | 6.8 (±2.4) | |
Yes | 145 | 6.9 (±2.2) | |
Steroids | 0.73 | ||
No | 21 | 7.1 (±2.2) | |
Yes | 259 | 6.9 (±2.3) | |
Calcineurin inhibitor | 0.61 | ||
Tacrolimus | 204 | 6.9 (±2.3) | |
Cyclosporine | 20 | 6.7 (±2.7) | |
None | 8 | 7.6 (±2.1) | |
Type not known | 72 | 6.9 (±2.1) | |